Key result
Computational modeling of full-length ADAR1p150 revealed that dsRBD3 and CDD remain structurally stable, while ZBDs and dsRBD1/2 exhibit extensive flexibility to facilitate RNA recognition.
Why the study?
Therapeutic development targeting ADAR1 has been hindered by a lack of structural insight into the full-length protein and how its dynamic behavior influences RNA-editing specificity and protein-protein interactions.
Computational modeling of full-length ADAR1p150 reveals domain-specific flexibility and stability, providing a framework for understanding its RNA-editing specificity and therapeutic targeting.
ADAR1 remains an emerging target in neurological and immune disorders; leaves open selective inhibitor development for clinical translation.
Adenosine deaminase acting on RNA 1 (ADAR1) is an essential RNA-editing enzyme responsible for the hydrolytic deamination of adenosine to inosine (A-to-I) in double-stranded RNA. This editing mechanism plays a critical role in gene regulation, particularly in neural and immune contexts. Dysregulation of ADAR1 activity has been implicated in neurological disorders, cancer progression, and immune dysfunction, making ADAR1 an emerging therapeutic target. However, progress in therapeutic development has been hindered by the lack of structural insight into the full-length protein and how its dynamic behavior influences RNA-editing specificity and protein-protein interactions. In this study, we present computational models of the full-length ADAR1p150 isoform generated by homology modeling and further analyzed using molecular dynamics (MD) simulations and principal component analysis (PCA). Our analyses reveal that the dsRBD3 and CDD remain structurally stable, crucial for protein binding and catalytic function, whereas ZBDs and dsRBD1/2 exhibit extensive flexibility, particularly in inter-domain loops, facilitating RNA recognition indicative of conformational selection and fly-casting mechanisms. Free-energy landscape mapping identifies multiple low-energy conformations, highlighting conserved domain cores and flexible loop arrangements. Together, these findings underscore the importance of ADAR1's dynamic architecture in regulating its function. By linking static structural information with dynamic behavior, the full-length models and dynamic insights presented here provide a valuable framework for future studies of ADAR1 complex formation, editing specificity, and therapeutic targeting.
No takes yet. Share an insight, caveat, or question.
Ashley et al. (2025) studied this question. Computational modeling and molecular dynamics simulations was evaluated on Structural stability and flexibility of ADAR1 domains. Computational modeling of full-length ADAR1p150 revealed that dsRBD3 and CDD remain structurally stable, while ZBDs and dsRBD1/2 exhibit extensive flexibility to facilitate RNA recognition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: